Compounds > triazoles
Page last updated: 2024-08-24

triazoles and Brain Infarction

triazoles has been researched along with Brain Infarction in 3 studies

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (33.33)18.2507
2000's0 (0.00)29.6817
2010's2 (66.67)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Bae, E; Chen, CT; Kuan, HH; Shia, KS; Song, JS; Wang, Y; Wu, CH; Wu, KJ; Yeh, KC; Yu, SJ1
Gyo, K; Hato, N; Hinohira, Y; Hyodo, J; Takahashi, H; Ugumori, T; Wakisaka, H1
Abbracchio, MP; Cattabeni, F1

Other Studies

3 other study(ies) available for triazoles and Brain Infarction

ArticleYear
A Novel CXCR4 Antagonist CX549 Induces Neuroprotection in Stroke Brain.
    Cell transplantation, 2017, 04-13, Volume: 26, Issue:4

    Topics: Animals; Anti-Inflammatory Agents; Behavior, Animal; Benzylamines; Brain; Brain Infarction; Chemotaxis; Cyclams; HEK293 Cells; Hematopoietic Stem Cell Mobilization; Hematopoietic Stem Cells; Heterocyclic Compounds; Humans; Interleukin-6; Male; Mice, Inbred C57BL; Neurons; Neuroprotection; Neuroprotective Agents; Quinazolines; Rats, Sprague-Dawley; Receptors, CXCR4; Stroke; Triazoles; Tumor Necrosis Factor-alpha

2017
Clinical features and outcomes of four patients with invasive fungal sinusitis.
    Auris, nasus, larynx, 2011, Volume: 38, Issue:2

    Topics: Aged; Antifungal Agents; Aspergillosis; Biopsy; Blindness; Brain Infarction; Candidiasis; Cavernous Sinus; Combined Modality Therapy; Debridement; Early Diagnosis; Echinocandins; Fatal Outcome; Female; Follow-Up Studies; Humans; Infusions, Intravenous; Lipopeptides; Magnetic Resonance Imaging; Male; Maxillary Sinusitis; Micafungin; Middle Aged; Orbit Evisceration; Orbital Diseases; Postoperative Complications; Pyrimidines; Sphenoid Sinusitis; Tomography, X-Ray Computed; Triazoles; Voriconazole

2011
Brain adenosine receptors as targets for therapeutic intervention in neurodegenerative diseases.
    Annals of the New York Academy of Sciences, 1999, Volume: 890

    Topics: Adenosine; Animals; Astrocytes; Brain Infarction; Brain Ischemia; Cell Death; Humans; Neurodegenerative Diseases; Neuroprotective Agents; Purinergic P1 Receptor Agonists; Purinergic P1 Receptor Antagonists; Pyrimidines; Rats; Receptor, Adenosine A2A; Receptor, Adenosine A3; Receptors, Purinergic P1; Triazoles

1999